GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...

Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

7-OH occurs naturally at low levels in the kratom plant, but the FDA is most concerned with products that contain 7-OH in ...

Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Emily Sutton, Pharm.D., CDCES, a clinical pharmacist, shares, “Compounded GLP-1 medications contain a version of the drug (not an exact copy of the FDA-approved drug) that a pharmacy makes.

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.